Literature DB >> 18370962

Value and increased cost sharing in the American health care system.

Michael Chernew, A Mark Fendrick.   

Abstract

Mesh：

Year:  2008        PMID： 18370962      PMCID： PMC2442370          DOI： 10.1111/j.1475-6773.2008.00847.x

Source DB:  PubMed          Journal:  Health Serv Res        ISSN： 0017-9124            Impact factor:   3.402


× No keyword cloud information.
  13 in total

1.  Can disease management reduce health care costs by improving quality?

Authors:  Bruce Fireman; Joan Bartlett; Joe Selby
Journal:  Health Aff (Millwood)       Date:  2004 Nov-Dec       Impact factor: 6.301

2.  The value of coronary heart disease care for the elderly: 1987-2002.

Authors:  Allison B Rosen; David M Cutler; Douglas M Norton; Hsou Mei Hu; Sandeep Vijan
Journal:  Health Aff (Millwood)       Date:  2007 Jan-Feb       Impact factor: 6.301

3.  Impact of decreasing copayments on medication adherence within a disease management environment.

Authors:  Michael E Chernew; Mayur R Shah; Arnold Wegh; Stephen N Rosenberg; Iver A Juster; Allison B Rosen; Michael C Sokol; Kristina Yu-Isenberg; A Mark Fendrick
Journal:  Health Aff (Millwood)       Date:  2008 Jan-Feb       Impact factor: 6.301

4.  Value-based insurance design: aligning incentives to bridge the divide between quality improvement and cost containment.

Authors:  A Mark Fendrick; Michael E Chernew
Journal:  Am J Manag Care       Date:  2006-12       Impact factor: 2.229

5.  Impact of multitiered copayments on the use and cost of prescription drugs among Medicare beneficiaries.

Authors:  Boyd H Gilman; John Kautter
Journal:  Health Serv Res       Date:  2008-04       Impact factor: 3.402

6.  Analyzing the evidence on European health care reforms.

Authors:  R B Saltman; J Figueras
Journal:  Health Aff (Millwood)       Date:  1998 Mar-Apr       Impact factor: 6.301

7.  A benefit-based copay for prescription drugs: patient contribution based on total benefits, not drug acquisition cost.

Authors:  A M Fendrick; D G Smith; M E Chernew; S N Shah
Journal:  Am J Manag Care       Date:  2001-09       Impact factor: 2.229

8.  Cost-effectiveness of full medicare coverage of angiotensin-converting enzyme inhibitors for beneficiaries with diabetes.

Authors:  Allison B Rosen; Mary Beth Hamel; Milton C Weinstein; David M Cutler; A Mark Fendrick; Sandeep Vijan
Journal:  Ann Intern Med       Date:  2005-07-19       Impact factor: 25.391

9.  How effective are copayments in reducing expenditures for low-income adult Medicaid beneficiaries? Experience from the Oregon health plan.

Authors:  Neal T Wallace; K John McConnell; Charles A Gallia; Jeanene A Smith
Journal:  Health Serv Res       Date:  2008-01-29       Impact factor: 3.402

10.  Value-based insurance design: a "clinically sensitive, fiscally responsible" approach to mitigate the adverse clinical effects of high-deductible consumer-directed health plans.

Authors:  A Mark Fendrick; Michael E Chernew
Journal:  J Gen Intern Med       Date:  2007-06       Impact factor: 5.128
View more
  3 in total

1.  Out-of-pocket payments in arthritis: spur to prudent purchasing or red herring?

Authors:  Edward Yelin
Journal:  Arthritis Rheum       Date:  2008-08

2.  Prescription copay reduction program for diabetic employees: impact on medication compliance and healthcare costs and utilization.

Authors:  Kavita V Nair; Kerri Miller; Joseph Saseen; Pamela Wolfe; Richard Read Allen; Jinhee Park
Journal:  Am Health Drug Benefits       Date:  2009-01

3.  Lung cancer treatment costs, including patient responsibility, by disease stage and treatment modality, 1992 to 2003.

Authors:  Lauren E Cipriano; Dorothy Romanus; Craig C Earle; Bridget A Neville; Elkan F Halpern; G Scott Gazelle; Pamela M McMahon
Journal:  Value Health       Date:  2011-01       Impact factor: 5.725
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.